Healthy Living South Dakota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living South Dakota.

Press releases published on May 20, 2026

PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference
IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Sustainability Leader Ashley McKeon Selected as Soil Health Institute’s President and CEO
PharmAla Biotech Signs Term Sheet to License Exclusive U.S. Rights to ALA-002, Its Next-Generation MDMA Therapeutic, to Jupiter Neurosciences, Inc. (NASDAQ: JUNS) in a Transaction Valued at Over $100 Million
Protara Therapeutics to Present at the TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA
Madrigal to Present New Data from the Company’s MASH Program at EASL 2026 Demonstrating the Effects of Rezdiffra on Markers of Cardiovascular and Portal Hypertension Risk
23andMe Partners with HealthEx to Connect Medical Records with Your DNA for the Future of Personalized Medicine
Humacyte Announces Symvess® is Now Under Contract with the Strategic Acquisition Center (SAC) of the U.S. Department of Veterans Affairs
Phathom Pharmaceuticals Highlights Breadth of Independent Vonoprazan Research at Digestive Disease Week 2026 Annual Meeting
Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway
XCHANGE ‘26 Attendee Insights Highlight Healthcare AI’s Shift From Adoption to Operational Scale
Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership
Annovis Announces Pricing of $15.0 Million Public Offering of Common Stock and Accompanying Warrants
Dyne Therapeutics Announces Initiation of Phase 3 FORZETTO Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD) Ahead of Planned BLA Submission for U.S. Accelerated Approval
Lung Health Foundation Says Canada’s Current Access System to Emerging Therapies is Moving Slower than Modern Medicine
Jupiter Neurosciences Secures $100M Term Sheet for Exclusive U.S. Rights to ALA-002, a Next-Generation MDMA Therapeutic from PharmAla Biotech
Kraig Biocraft Laboratories Highlights Technical Breakthrough of Its Immortalized Silk Gland Cell Platform
Repligen Announces Publication of the Company’s 2025 Corporate Sustainability Report
Emergent BioSolutions to Participate in Upcoming Investor Conferences

Share this page:

Sign up for:

Healthy Living South Dakota

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.